DrugPatentWatch Database Preview

Keryx Biopharms Company Profile

« Back to Dashboard

What is the competitive landscape for KERYX BIOPHARMS, and what generic alternatives to KERYX BIOPHARMS drugs are available?

KERYX BIOPHARMS has one approved drug.

There are fourteen US patents protecting KERYX BIOPHARMS drugs.

There are one hundred and twelve patent family members on KERYX BIOPHARMS drugs in twenty-six countries.

Summary for Keryx Biopharms

International Patents:	112
US Patents:	14
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Keryx Biopharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	9,387,191		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,609,896		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,754,258		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	5,753,706		Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	8,846,976
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	7,767,851		Y	Y
Keryx Biopharms	AURYXIA	ferric citrate	TABLET;ORAL	205874-001	Sep 5, 2014		RX	Yes	Yes	9,328,133		Y	Y

International Patents for Keryx Biopharms Drugs

Country	Document Number	Estimated Expiration
Spain	2503717
Denmark	1601680
European Patent Office	2813511
Hungary	E025264
Hong Kong	1205129
European Patent Office	3066923
Spain	2539635

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Keryx Biopharms